Juan‐Miguel Jimenez
Johnson & Johnson (United States)(US)Drug Discovery Laboratory (Norway)(NO)Galapagos (Belgium)(BE)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Cytokine Signaling Pathways and Interactions, Alkaloids: synthesis and pharmacology, Chemical synthesis and alkaloids, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Synthesis of the First Members of a New Class of Biologically Active Bryostatin Analogues(1998)102 cited
- → Synthesis and Biological Evaluation of 3,4-Diaryloxazolones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors(1999)98 cited
- → Discovery and Structure−Activity Relationship of 3-Aminopyrid-2-ones as Potent and Selective Interleukin-2 Inducible T-Cell Kinase (Itk) Inhibitors(2011)60 cited
- → Design and Optimization of Selective Protein Kinase C θ (PKCθ) Inhibitors for the Treatment of Autoimmune Diseases(2013)47 cited
- → Nucleophilic Addition of 1-Acetylindole Enolates to Pyridinium Salts. Stereoselective Formal Synthesis of (±)-Geissoschizine and (±)-Akagerine via 1,4-Dihydropyridines(1999)44 cited
- → Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors(2004)29 cited